These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20678433)

  • 1. [The present situation and pondering on antiviral therapy in patients with decompensated cirrhosis].
    Wan MB
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):483-5. PubMed ID: 20678433
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral therapy of decompensated hepatitis B virus-related cirrhosis.
    Chen GC; Yu T; Huang KH; Chen QK
    Chin Med J (Engl); 2012 Jan; 125(2):373-7. PubMed ID: 22340574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral treatment for hepatitis B virus related liver cirrhosis].
    Xie Q; Gui HL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):837-8. PubMed ID: 17125614
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?
    Navasa M; Forns X
    J Hepatol; 2007 Feb; 46(2):185-8. PubMed ID: 17161494
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis.
    Zoulim F; Radenne S; Ducerf C
    Liver Transpl; 2008 Oct; 14 Suppl 2():S1-7. PubMed ID: 18825719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Emphasis on the antiviral therapy for decompensated hepatitis B-related cirrhosis].
    Fu QC; Chen CW
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(23):1585-6. PubMed ID: 20979741
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current perspectives on antiviral therapy in hepatitis C-infected patients with decompensated cirrhosis].
    Zhang HF; Zhu SS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):413-4. PubMed ID: 24490303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
    Wang L; Yan J; Zhang ZH; Wang JB; Du YZ; Li XY; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):585-8. PubMed ID: 15504286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of clinical diagnosis, and antiviral therapy for HBV-related cirrhosis].
    o Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):327-335. PubMed ID: 25222972
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea].
    Jung S; Suh DJ; Park HJ; Park YH; Song HG; Lee HC; Chung YH; Lee YS
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):418-27. PubMed ID: 12506246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
    Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus-related cirrhosis: natural history and treatment.
    Chu CM; Liaw YF
    Semin Liver Dis; 2006 May; 26(2):142-52. PubMed ID: 16673292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of long-term lamivudine therapy in the patients with decompensated liver cirrhosis secondary to hepatitis B].
    Park TW; Park YM; Bae SH; Jang JW; Nam SW; Choi JY; Yoon SK; Cho SH; Yang JM; Han NI; Ahn BM; Lee YS; Lee CD; Park DH
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):428-35. PubMed ID: 12506247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [One year and half treatment with lamivudine in active cirrhosis resulting from chronic hepatitis B].
    Zeng WQ; Guo SH; Zhang DZ; Zhou Z; Ren H; Zhang QH; Wang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):176-8. PubMed ID: 12681069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.